These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. McCallum RW; Fink SM; Lerner E; Berkowitz DM Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852 [TBL] [Abstract][Full Text] [Related]
29. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835 [TBL] [Abstract][Full Text] [Related]
31. Prokinetics and fundic relaxants in upper functional GI disorders. Tack J Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266 [TBL] [Abstract][Full Text] [Related]
32. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. Hawkyard CV; Koerner RJ J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772 [TBL] [Abstract][Full Text] [Related]
33. Cisapride. Washabau RJ; Hall JA J Am Vet Med Assoc; 1995 Nov; 207(10):1285-8. PubMed ID: 7591920 [No Abstract] [Full Text] [Related]
34. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Briejer MR; Akkermans LM; Schuurkes JA Pharmacol Rev; 1995 Dec; 47(4):631-51. PubMed ID: 8746557 [No Abstract] [Full Text] [Related]
35. Ghrelin receptor agonists: a new class of prokinetic agents. Neurogastroenterol Motil; 2010 Oct; 22(10):1043-4. PubMed ID: 20840719 [No Abstract] [Full Text] [Related]
36. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Megens AA; Awouters FH; Niemegeers CJ Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352 [TBL] [Abstract][Full Text] [Related]
37. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
38. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862 [TBL] [Abstract][Full Text] [Related]
39. Nonobstructive gastroparesis in amyloidosis improved with metoclopramide. Reddy AB; Wright RA; Wheeler GE; Nazer H Arch Intern Med; 1983 Feb; 143(2):247-8. PubMed ID: 6824392 [TBL] [Abstract][Full Text] [Related]
40. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy. Nandurkar S J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]